FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma

HPB

Volumn 13, Issue 4, 2011, Pages 256-262

  Ruys, Anthony T ^a   Bennink, Roel J ^a   Van Westreenen, Henderik L ^a   Engelbrecht, Marc R ^a   Busch, Olivier R ^a   Gouma, Dirk J ^a   Van Gulik, Thomas M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

hilar cholangiocarcinoma (HCCA); positron emission tomography computed tomography (PET CT); standardized uptake value (SUV)

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; DRUG UPTAKE; FEMALE; HILAR CHOLANGIOCARCINOMA; HUMAN; INTRAOPERATIVE PERIOD; LAPAROSCOPY; LYMPH NODE METASTASIS; MALE; PRIMARY TUMOR; RADIOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; STANDARDIZED UPTAKE VALUE;

EID: 79952933965     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00280.x     Document Type: Article

References (28)

1. Klatskin G,. (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumour with distinctive clinical and pathological features. Am J Med 38: 241-256.
2. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, et al,. (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245: 755-762. (Pubitemid 46684105)
3. Dinant S, Gerhards MF, Rauws EA, Busch OR, Gouma DJ, Van Gulik TM., (2006) Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumour). Ann Surg Oncol 13: 872-880. (Pubitemid 43727373)
4. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M., (1999) Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 230: 663-671. (Pubitemid 30191828)
5. Rea DJ, Munoz-Juarez M, Farnell MB, Donohue JH, Que FG, Crownhart B, et al,. (2004) Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 139: 514-523.
6. Gerhards MF, Vos P, Van Gulik TM, Rauws EA, Bosma A, Gouma DJ., (2001) Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg 88: 48-51. (Pubitemid 32066056)
7. Kloek JJ, van Delden OM, Erdogan D, ten Kate FJ, Rauws EA, Busch OR, et al,. (2008) Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World J Gastroenterol 14: 5032-5038.
8. Van Gulik TM, Gouma DJ,. (2007) Changing perspectives in the assessment of resectability of hilar cholangiocarcinoma. Ann Surg Oncol 14: 1969-1971. (Pubitemid 46988263)
9. Ito F, Cho CS, Rikkers LF, Weber SM., (2009) Hilar cholangiocarcinoma: current management. Ann Surg 250: 210-218.
10. 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients. Eur J Nucl Med Mol Imaging 32: 589-592. (Pubitemid 41214202)
11. Farma JM, Santillan AA, Melis M, Walters J, Belinc D, Chen DT, et al,. (2008) PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol 15: 2465-2471.
12. Bar-Shalom R, Guralnik L, Tsalic M, Leiderman M, Frenkel A, Gaitini D, et al,. (2005) The additional value of PET/CT over PET in FDG imaging of oesophageal cancer. Eur J Nucl Med Mol Imaging 32: 918-924. (Pubitemid 41205662)
13. 18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer. Oncol Rep 7: 85-87.
14. Reske SN, Kotzerke J,. (2001) FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, 'Onko-PET III', 21 July and 19 September 2000. Eur J Nucl Med 28: 1707-1723. (Pubitemid 33036116)
15. Gerhards MF, Gonzalez DG, ten Hoopen-Neumann H, Van Gulik TM, de Wit LT, Gouma DJ., (2000) Prevention of implantation metastases after resection of proximal bile duct tumours with preoperative low dose radiation therapy. Eur J Surg Oncol 26: 480-485.
16. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo RP, Schwartz LH, et al,. (2003) Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7: 325-330. (Pubitemid 36875770)
17. Dinant S, de Graaf W, Verwer BJ, Bennink RJ, van Lienden KP, Gouma DJ, et al,. (2007) Risk assessment of post-hepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48: 685-692. (Pubitemid 47604966)
18. van den Esschert JW, de Graaf W, van Lienden KP, Busch OR, Heger M, van Delden OM, et al,. (2009) Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization: recovery after PVE and liver resection. J Gastrointest Surg 13: 1464-1469.
19. International Union Against Cancer (UICC) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York.
20. Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, et al,. (2008) The Netherlands protocol for standardization and quantification of FDG whole-body PET studies in multicentre trials. Eur J Nucl Med Mol Imaging 35: 2320-2333.
21. Jadvar H, Henderson RW, Conti PS,. (2007) [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr 31: 223-228. (Pubitemid 46573360)
22. 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30: 1467-1472. (Pubitemid 37356113)
23. 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol 45: 560-566.
24. Li J, Kuehl H, Grabellus F, Müller SP, Radunz S, Antoch G, et al,. (2008) Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol 98: 438-443.
25. Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W, et al,. (2006) Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 45: 43-50. (Pubitemid 43850623)
26. Erdogan D, Kloek JJ, ten Kate FJ, Rauws EA, Busch OR, Gouma DJ, et al,. (2008) Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg 95: 727-734.
27. 18F-FDG PET/CT: preliminary results for 22 patient studies. J Nucl Med 46: 1158-1163. (Pubitemid 43741078)
28. 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. Am J Gastroenterol 103: 1145-1151. (Pubitemid 351677961)